GOLD 2027 COPD update
Group A: start with a LAMA. GOLD also recommends baseline chest CT where available and expands guidance on borderline spirometry and cardiovascular risk after exacerbations.
Read the clinical summary updatesinmedicine.com/articl…
🤖 Made with AI
Migraine prevention in 2026. Taiwan includes CGRP-targeted therapy among first-line options. Spain’s GECSEN Delphi panel sets a three-month goal of fewer than four migraine or moderate to severe headache days per month. Read the clinical article updatesinmedicine.com/articl…
WHO’s 2026 guideline on type 1 diabetes in children and adolescents covers early recognition, DKA, insulin regimens, glucose monitoring and screening for eye and kidney complications.
Read the clinical summary: updatesinmedicine.com/articl…
Lupus care in 2026. The GLADEL–PANLAR update stratifies skin and joint treatment by severity. For active proliferative lupus nephritis, the add-on depends on the conventional regimen. Read the clinical update: updatesinmedicine.com/articl…
AustrAIHANZ 2026: confirm haemolysis and interpret the DAT in context. If profound anaemia causes instability or end-organ ischaemia, follow local emergency transfusion policy without waiting for full compatibility testing.
Read more: updatesinmedicine.com/articl…
In warm AIHA, plan the steroid taper early. AustrAIHANZ recommends rituximab upfront with prednisolone or early if response is minimal after at least 2 weeks. Read the consensus summary:
updatesinmedicine.com/articl…
Resuscitation 2026: measured ventilation, adult-size bags and selective fluids during adult CPR. Three changes, with important exceptions. Weak recommendations; very-low-certainty evidence.
Read our clinical update:
updatesinmedicine.com/articl…
Read what changed, the practical implications and evidence limits in our full clinical update:
updatesinmedicine.com/articl…
OPTIMAL-STROKE: in stable patients after ischaemic stroke/TIA, SBP targets <120 vs <140 mmHg yielded CV events of 10.9% vs 13.5% (HR 0.79) over 3.9 years. More renal events; monitor kidney function and electrolytes.
updatesinmedicine.com/articl…
Acute pancreatitis in 2026: diagnose, classify severity and reassess fluids. Persistent organ failure >48 h defines severe disease; deterioration needs earlier escalation. (1/3)
2026 iLATAM-AP guideline:
doi.org/10.1002/ueg2.70190
Early feeding if tolerated. Urgent ERCP for biliary pancreatitis with cholangitis. Antibiotics for suspected/confirmed infection—not prophylaxis for sterile necrosis. Collections: delay intervention when feasible; step up when needed. (2/3)
Mild biliary pancreatitis: cholecystectomy during admission. More severe disease: individualise timing around recovery and collections. (3/3)
Explore more clinician resources:
updatesinmedicine.com
Educational summary; apply clinical judgement.
4
287
Acute PE in 2026: A–E categories link clinical severity to care—from outpatient assessment to emergency escalation.
Start with the framework and discharge safety checks. (1/3)
doi.org/10.1161/CIR.00000000…
Slides 5–8: the RV/biomarker matrix, incipient failure, emergency categories and respiratory thresholds—together in the bedside pathway.
1
2
241
ICU metabolic acidosis: a Bayesian meta-analysis of 4 RCTs (n=1,544) found stronger evidence for less RRT initiation than for improved short-term survival. Findings support selective—not routine—bicarbonate use.
link.springer.com/article/10…
🤖 Made with AI
1/3 | ACLF in 2026: a five-society consensus. Advanced chronic liver disease + liver failure + extrahepatic dysfunction/failure. Slides 1–4 cover diagnosis, Types A/B and harmonised grades. Older regional grades differ. AI illustrations. #ACLF
2/3 | Slides 5–8: kidney/HE criteria, respiratory and circulatory failure, precipitants and selected ICU principles. Vasopressors for HRS-AKI alone do not count as circulatory failure. Educational summary, not a complete protocol.
3/3 | Slides 9–10: reassess trajectory and evaluate transplantation early. Worked cases are illustrative, not study participants. Evidence strength varies. Source: Hepatol Int, 30 Oct 2026. doi.org/10.1007/s12072-026-1…





























































